Calumba, Froilan C.
HRN: 41-27-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
CEFTRIAXONE 1G (VIAL)
04/20/2022
04/26/2022
IV
2G
OD
MULTIPLE CARERATIONS (HEAD AND THORAX)
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes